Anti-HPV16 E6 + HPV18 E6 antibody [C1P5] (ab70)

Mouse monoclonal HPV16 E6 + HPV18 E6 antibody [C1P5]. Validated in WB, IP, IHC and tested in Human papillomavirus. Cited in 16 publication(s). Independently reviewed in 2 review(s).

Publishing research using ab70? Please let us know so that we can cite the reference in this datasheet.

ab70 has been referenced in 18 publications.

  • Jiang Z  et al. Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer. Transl Oncol 12:1289-1295 (2019). PubMed: 31325765
  • Wang X  et al. Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway. J Med Virol N/A:N/A (2017). WB ; Human . PubMed: 28480962
  • Xi R  et al. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo. Oncotarget 7:57050-57065 (2016). WB . PubMed: 27489353
  • Phaeton R  et al. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer. Cancer Med 5:9-16 (2016). PubMed: 26625938
  • Sikander M  et al. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Sci Rep 6:36594 (2016). PubMed: 27824155
  • Phaëton R  et al. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer. Immunotherapy 7:631-40 (2015). PubMed: 26098137
  • Zhang M  et al. In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines. Cancer Biol Ther 16:1231-40 (2015). PubMed: 26046692
  • Xie X  et al. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma. Oncogene N/A:N/A (2013). PubMed: 23474763
  • Herfs M  et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A 109:10516-21 (2012). Human papillomavirus . PubMed: 22689991
  • Phaeton R  et al. The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)Re-labeled anti-E6 C1P5 antibody in cervical cancer in mice. Cancer 116:1067-1074 (2010). PubMed: 20127955
  • Lawson JS  et al. Koilocytes indicate a role for human papilloma virus in breast cancer. Br J Cancer 101:1351-6 (2009). IHC-P . PubMed: 19773762
  • Allison SJ  et al. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging (Albany NY) 1:316-27 (2009). PubMed: 20157519
  • Lea JS  et al. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Reprod Sci 14:20-8 (2007). PubMed: 17636212
  • Zhang Y  et al. BRCA1 interaction with human papillomavirus oncoproteins. J Biol Chem 280:33165-77 (2005). WB . PubMed: 15983032
  • Sirianni N  et al. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 10:6929-37 (2004). PubMed: 15501971
  • Abdulkarim B  et al. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene 21:2334-46 (2002). PubMed: 11948417
  • Kobayashi A  et al. Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. Am J Pathol 160:151-64 (2002). PubMed: 11786409
  • Banks L  et al. Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol 68 ( Pt 5):1351-9 (1987). PubMed: 3033140

For licensing inquiries, please contact

Sign up